Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K N Woodward

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Veterinary Pharmacology and Therapeutics|March 21, 1998
The use of microbiological end-points in the safety evaluation and elaboration of maximum residue limits for veterinary drugs intended for use in food producing animalsK N Woodward
Veterinary and Human Toxicology|April 1, 1991
Hypersensitivity in humans and exposure to veterinary drugsK N Woodward
Human & Experimental Toxicology|July 12, 2005
The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription productsK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 2. Veterinary pharmacovigilance in practice -- the operation of a spontaneous reporting scheme in a European Union country -- the UK, and schemes in other countriesK N Woodward
Current Pharmaceutical Biotechnology|November 2, 2011
Toxicity in animals: target speciesK N Woodward
Human & Experimental Toxicology|January 1, 1992
Carcinogenicity of sulphadimidineK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 4. Adverse reactions in humans to veterinary medicinal productsK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 5. Causality and expectednessK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 6. Predictability of adverse reactions in animals from laboratory toxicology studiesK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 1. The legal basis in the European UnionK N Woodward
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Veterinary Pharmacology and Therapeutics|March 21, 1998
The use of microbiological end-points in the safety evaluation and elaboration of maximum residue limits for veterinary drugs intended for use in food producing animalsK N Woodward
Veterinary and Human Toxicology|April 1, 1991
Hypersensitivity in humans and exposure to veterinary drugsK N Woodward
Human & Experimental Toxicology|July 12, 2005
The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription productsK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 2. Veterinary pharmacovigilance in practice -- the operation of a spontaneous reporting scheme in a European Union country -- the UK, and schemes in other countriesK N Woodward
Current Pharmaceutical Biotechnology|November 2, 2011
Toxicity in animals: target speciesK N Woodward
Human & Experimental Toxicology|January 1, 1992
Carcinogenicity of sulphadimidineK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 4. Adverse reactions in humans to veterinary medicinal productsK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 5. Causality and expectednessK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 6. Predictability of adverse reactions in animals from laboratory toxicology studiesK N Woodward
Journal of Veterinary Pharmacology and Therapeutics|April 22, 2005
Veterinary pharmacovigilance. Part 1. The legal basis in the European UnionK N Woodward
Pageof 2